Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: Initial clinical outcomes

被引：0
作者：
Sun, Jie [1 ]
Li, Dong [1 ]
Xue, Wei [1 ]
Zhou, Lixin [1 ]
Huang, Yiran [1 ]
机构：
[1] Shanghai Renji Hospital, School of Medicine, Affiliated to Shanghai Jiaotong University
来源：
Zhongguo Jiguang/Chinese Journal of Lasers | 2009年 / 36卷 / 10期
关键词：
Benign prostatic hyperplasia; Green laser; KTP crystal; Medical optics; Photoselective vaporization of the prostate;
D O I：
10.3788/CJL20093610.2687
中图分类号：
学科分类号：
摘要：
To evaluate the efficacy and safety of photoselective vaporization of the prostate (PVP) for the treatment of benign prostatic hyperplasia (BPH), total 24 patients (mean age of 71.00±9.74 years) with BPH underwent PVP in our hospital by using Realton 100 W surgical green laser system. Prostate size, operation time, blood loss during operation, catheterization time and hospital stay were recorded. International prostate symptom score (I-PSS), maximum flow rate (Qmax), post void residual urine (PVR) were compared to the baseline. The results show that PVP is a safe and effective treatment for BPH, especially suitable for aged, high-risk or anticoagulant therapy patients. PVP has less bleeding during operation, shorter catheterization time and hospital stay. More follow-ups are needed to evaluate its long-term efficiency.
引用
收藏
页码：2687 / 2690
页数：3
相关论文
共 17 条
  • [1] Lin Y., Lu Y., Advancement of medical treatment in benign hyperplasia of prostate, Yunnan J. Tradi. Chin. Med. and Mat. Med., 28, 4, pp. 48-50, (2007)
  • [2] Mao H., Qi S., Li L., Et al., Drug for benign prostatic hyperplasia, J. Jilin Med. Col., 2, pp. 113-115, (2009)
  • [3] Fu Y., Fen Z., Long follow-up of PVP in the clinical management of BPH: Long term efficacy comparable to TURP, J. Clin. Urol., 22, 5, pp. 398-399, (2007)
  • [4] Cao J., Qi J., Yang N., The correlation between hemorrhage in TURP operation and the expression of MVD and VEGF in BPH, Mod. Urol., 14, 1, pp. 29-31, (2009)
  • [5] Costello A.J., Bowsher W.G., Bolton D.M., Et al., Laser ablation of the prostate in patients with benign prostatic hypertrophy, Br. J. Urol., 69, 6, pp. 603-608, (1992)
  • [6] Kuntzman R.S., Malek R.S., Barrett D.M., Et al., High-power (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers, Urology, 49, 5, pp. 703-708, (1997)
  • [7] Malek R.S., Barrett D.M., Kuntzman R.S., High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later, Urology, 51, 2, pp. 254-256, (1998)
  • [8] Hu J., Liu W., Tan X., Et al., Transurethral vaporization using greenlight laser for urethrostenosis or urethratresia, Chin. J. Laser Med. and Surg., 18, 3, pp. 160-162, (2009)
  • [9] Malek R.S., Barrett D.M., Kuntzman R.S., High-power potassium-titanyl-phosphate laser vaporization prostatectomy, Mayo. Clin. Proc., 73, 8, pp. 798-801, (1998)
  • [10] Jacques S.L., Laser-tissue interaction. Photochemical, photothermal, and photomechanical, Surg. Clin N. Am., 72, 3, pp. 531-538, (1992)
12